(Q28286998)

English

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study

scientific article

In more languages

Statements

scholarly article

0 references

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study (English)

0 references

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C P Thakur

1

0 references

A K Pandey

2

0 references

G P Sinha

3

0 references

S Roy

4

0 references

K Behbehani

5

0 references

P Olliaro

6

0 references

language of work or name

0 references

publication date

1996

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

0 references

90

0 references

3

0 references

319-22

0 references

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

A Comparison of Three Dosage Regimens of Sodium Stibogluconate in the Treatment of Visceral Leishmaniasis in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Liposomal amphotericin B in drug-resistant visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Cardiopulmonary toxicity after liposomal amphotericin B infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Amphotericin B for second-line treatment of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

21 January 2018

Comparison of Regimes of Treatment of Antimony-Resistant Kala-Azar Patients: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990271-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0035-9203(96)90271-0

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28286998&oldid=1951611262"